Company intelligence / Profile preview
Pharmstandard
Kursk, Kursk, Russiapharmstd.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Pharmstandard leads the Russian pharmaceutical market with over two decades of experience. It produces more than 400 pharmaceutical products across multiple therapeutic areas. The company operates four GMP-certified manufacturing sites with an annual capacity exceeding 1.7 billion packages. Over 100 of its products are on Russia’s List of Vital and Essential Pharmaceuticals.
- Therapeutic areas
- OncologyEndocrinologyOtherGastroenterologyCardiovascular
- Modalities
- Small moleculesBiologics/biotechnology products
- Industry
- Pharma
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Joint venture with Generium to develop innovative biological products within Russia’s import substitution program.
Beyond the preview
Go deeper on Pharmstandard.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharmstandard.